Industry | 2018.01.08
Leading Taiwan-Based Biotech Company Signs Pristima® Software Subscription Agreement with Xybion Corporation
Xybion Corporation, a US-based global technology solutions provider for companies operating in the highly regulated industries, announced today that Level Biotechnology Inc., a leading Taiwan-based biotechnology company, has signed a software subscription agreement for Pristima, Xybion’s flagship pre-clinical solution, and Savante™, its popular module for production of FDA compliant SEND submissions.
(PRWeb January 08, 2018)
Read the full story at http://www.prweb.com/releases/2018/01/prweb15057333.htm
For more information, please visit
http://www.prweb.com/releases/2018/01/prweb15057333.htm
The Translation People Expands with Acquisition of Dialogue Language Services International views: 1494
Is AI Translation Quality Really Improving? views: 1484